Relapsed or Refractory Lymphoproliferative Malignancies
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Lymphoproliferative Malignancies
| Record | Firm | Date |
|---|---|---|
| Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies (NCT00481871) | Acrotech Biopharma Inc. | 2007-05-01 |
Track Relapsed or Refractory Lymphoproliferative Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.